Cargando…
COVID-19-Associated Pulmonary Aspergillosis Complicated by Severe Coronavirus Disease: Is Detection of Aspergillus in Airway Specimens Before Disease Onset an Indicator of Antifungal Prophylaxis?
A 55-year-old man was admitted for coronavirus disease 2019 (COVID-19)-related respiratory failure. He was treated with corticosteroids and tocilizumab in the intensive care unit. Aspergillus fumigatus (A. fumigatus) was isolated from his sputum on admission. However, no radiological findings sugges...
Autores principales: | Kitayama, Takaaki, Tone, Kazuya, Makimura, Koichi, Takagi, Masamichi, Kuwano, Kazuyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105287/ https://www.ncbi.nlm.nih.gov/pubmed/37069870 http://dx.doi.org/10.7759/cureus.36212 |
Ejemplares similares
-
Incremental Healthcare Costs and Outpatient Antifungal Treatment of Patients with Aspergillosis in the United States
por: Durden, Emily, et al.
Publicado: (2013) -
Inhaled Amphotericin B as Aspergillosis Prophylaxis in Hematologic
Disease: An Update
por: Duckwall, Madison J, et al.
Publicado: (2019) -
Diagnosis and Antifungal Prophylaxis for COVID-19 Associated Pulmonary Aspergillosis
por: Hawes, Armani M., et al.
Publicado: (2022) -
Invasive Aspergillosis by Aspergillus flavus: Epidemiology, Diagnosis, Antifungal Resistance, and Management
por: Rudramurthy, Shivaprakash M., et al.
Publicado: (2019) -
Aspergillus lentulus: An Under-recognized Cause of Antifungal Drug-Resistant Aspergillosis
por: Nematollahi, Saman, et al.
Publicado: (2021)